U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT06859853) titled 'A Study to Evaluate MWN109 Injection in Healthy Subjects' on Feb. 28.
Brief Summary: This study is a Phase1, randomized, double-blinded, and placebo-controlled study. In each cohort, enrolled participants will be randomized to receive either placebo or MWN109.
Study Start Date: March 02
Study Type: INTERVENTIONAL
Condition:
Overweight or Obese
Intervention:
DRUG: Placebo
Sub cutaneous injection on the abdomen by a qualified member of study staff.
DRUG: Subcutaneous single and mutiple dose
Sub cutaneous injection on the abdomen by a qualified member of study staff.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shanghai M...